OMEGAPHARM PIPERACILLIN AND TAZOBACTAM FOR INJECTION 2 g/0.25 g piperacillin 2g (as sodium) and tazobactam 250mg (as sodium) pow

国家: 澳大利亚

语言: 英文

来源: Department of Health (Therapeutic Goods Administration)

现在购买

公众评估报告 公众评估报告 (PAR)
23-11-2017

有效成分:

piperacillin sodium, Quantity: 2085 mg (Equivalent: piperacillin, Qty 2000 mg); tazobactam sodium, Quantity: 268 mg (Equivalent: tazobactam, Qty 250 mg)

可用日期:

Omegapharm

INN(国际名称):

piperacillin sodium,tazobactam sodium

药物剂型:

Injection, powder for

组成:

Excipient Ingredients:

给药途径:

Intravenous

每包单位数:

1 vial, 5 vials

处方类型:

(S4) Prescription Only Medicine

疗效迹象:

OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated for the treatment of serious bacterial infections caused by susceptible strains of beta-lactamase producing organisms in the following conditions, - lower respiratory tract infections, - urinary tract infections (complicated and uncomplicated), - intra-abdominal infections, - skin and skin structure infections, - bacterial septicaemia, and, - gynaecological infections. Children under the age of 12 years. In hospitalised children aged 2 to 12 years, OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated for the treatment of serious intra-abdominal infections. It has not been evaluated in this indication for paediatric patients below the age of 2 years. . While OMEGAPHARM PIPERACILLIN AND TAZOBACTAM is indicated only for the conditions listed above, it may be used as a single agent in the treatment of mixed infections caused by piperacillin susceptible and beta-lactamase producing, piperacillin resistant organisms. Appropriate culture and susceptibility tests sho

產品總結:

Visual Identification: White or off-white powder.; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

授权状态:

Registered

授权日期:

2011-09-08